Heparin Market Overview:
Drugs are often given to the patient just before a surgery to
decrease the chances of blood clot formation. Heparin, a glycosaminoglycan, is
one of such drugs that is anti-coagulant and can be used as a blood thinner as
it is able to keep the blood liquid and prevent blood clot formation in arteries,
veins as well as lungs. Therefore, it is used to treat a various health
problems including deep vein thrombosis, acute coronary syndrome, pulmonary
embolism, atrial fibrillation, cardiopulmonary bypass, hemofiltration during
cardiac surgery, and major orthopedic procedures such as hip and knee
replacements.
According to a report published by Allied Market Research,
the global heparin market size is projected to reach $11.01 billion with a
considerable CAGR from 2021 to 2028. The Asia-Pacific region is expected to
manifest the fastest growth rate, owing to growth in healthcare infrastructure
in developing countries, rise in initiatives by public & private
organizations, economic development, presence of untapped resources, and many
other factors.
Request for Sample Report for More Insights@ https://www.alliedmarketresearch.com/request-sample/6551
Impact of COVID-19 Pandemic on Heparin Market:
Moreover, the outbreak of COVID-19 pandemic led to have a
positive impact on the growth of the global heparin market, owing to rise in
demand for heparin. A large number of COVID-19 patients suffer from respiratory
syndrome. As a result, the demand for heparin has increased as it helps to
tackle respiratory inflation and thin the blood of those at risk of a blood
clot. Most of the COVID-19 patients were treated with prophylactic dose low
molecular weight heparin during the pandemic.
Furthermore, the demand of heparin is anticipated to rise
significantly with the increase in the aging population, which in turn, is
going to boost the growth of the global heparin market even more. With this
drift on board, the key market players are expanding their geographical presence
in the emerging economies to gather high market share. At the same time, the
availability of synthetic and semi-synthetic heparin mimetic that help to treat
cancer, coagulation, and inflammatory diseases is offering lucrative
opportunities for heparin adoption. Here, it is worth mentioning that the
global heparin market has a huge scope to capture exponential growth in the
years to come.
0 Comments